Abstract
Background: Bulk RNA sequencing (RNA-seq) has substantially advanced the understanding of pituitary neuroendocrine tumors (PitNETs). However, its limited ability to resolve cellular heterogeneity – particularly in samples containing residual non-tumor pituitary cells – remains a significant challenge. Objective: We developed and validated a tissue deconvolution framework using a reference dataset derived from single-nucleus RNA sequencing (snRNA-seq) of normal pituitary tissue, aimed at estimating cellular composition in PitNETs from bulk RNA-seq data and characterizing the tumor microenvironment (TME). Methods: Marker-based (CIBERSORT, MuSiC) and single-cell–based (CIBERSORTx, MuSiC) deconvolution approaches were benchmarked across simulated, pseudobulk, and bulk RNA-seq datasets to identify the most reliable tools. Results: CIBERSORTx demonstrated the highest sensitivity (r > 0.85) for detecting pituitary cell types, although accuracy decreased for TME components. Application to ten GH-secreting PitNETs with known histological contamination and to public datasets consistently revealed residual normal tissue across hormone-secreting subtypes, excluding silent tumors. Contaminated samples – averaging 43% ± 19% with CIBERSORTx and 37% ± 22% with CIBERSORT – displayed distinct transcriptomic profiles compared to uncontaminated, lineage-matched tumors, based on clustering analyses. Conclusion: This study establishes snRNA-seq–based deconvolution as a robust strategy for reconstructing cellular composition in PitNETs, mitigating the impact of histological contamination and improving the reliability of downstream transcriptomic analyses.
Author supplied keywords
Cite
CITATION STYLE
Dalle Nogare, M., Avallone, S., Picello, L., Puggina, D., Denaro, L., Sales, G., … Occhi, G. (2025). PitNET tissue deconvolution: tracing normal tissue residues and immune dynamics. Frontiers in Endocrinology, 16. https://doi.org/10.3389/fendo.2025.1674625
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.